Skip to main content
Industry News
Taysha gene therapy nabs orphan drug, rare pediatric tags
10/15/2020

Taysha Gene Therapies announced that the FDA granted both the rare pediatric disease and orphan drug designations to its investigational gene therapy TSHA-102 designed to treat Rett syndrome. The company is expected to file an investigational new drug application for the gene therapy in 2021.

Full Story: